Ifistatin Indications/Uses



Unique Pharm


Uni Drug
Full Prescribing Info
Therapy with lipid altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia.
Simvastatin is indicated in patients with coronary heart disease and hypercholesterolemia to reduce the risk of total mortality, reducing coronary death, to reduce the risk of non-fatal myocardial infarction and to reduce the risk for undergoing myocardial revascularisation procedures.
Simvastatin is indicated for the reduction of elevated total and LDL cholesterol levels in patients with primary hypercholesterolemia (Types IIa and IIb). Simvastatin is also indicated to reduce elevated LDL cholesterol levels in patients with combined hypercholesterolemia and hypertriglyceridemia where hypercholesterolemia is the major abnormality (Type II b hyperlipoproteinemia).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in